Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nukkleus (NUKK) EBITDA (2022 - 2025)

Historic EBITDA for Nukkleus (NUKK) over the last 4 years, with Q2 2025 value amounting to $2.9 million.

  • Nukkleus' EBITDA rose 27852.32% to $2.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $108.5 million, marking a year-over-year increase of 49785.12%. This contributed to the annual value of -$8.7 million for FY2024, which is 5018.32% up from last year.
  • Latest data reveals that Nukkleus reported EBITDA of $2.9 million as of Q2 2025, which was up 27852.32% from $102.9 million recorded in Q1 2025.
  • Nukkleus' EBITDA's 5-year high stood at $102.9 million during Q1 2025, with a 5-year trough of -$14.3 million in Q3 2023.
  • For the 4-year period, Nukkleus' EBITDA averaged around $8.0 million, with its median value being -$1.2 million (2022).
  • Its EBITDA has fluctuated over the past 5 years, first tumbled by 67385.05% in 2023, then skyrocketed by 438241.53% in 2025.
  • Nukkleus' EBITDA (Quarter) stood at -$1.2 million in 2022, then tumbled by 673.85% to -$9.0 million in 2023, then surged by 148.05% to $4.3 million in 2024, then crashed by 32.99% to $2.9 million in 2025.
  • Its EBITDA stands at $2.9 million for Q2 2025, versus $102.9 million for Q1 2025 and $4.3 million for Q3 2024.